Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Nikola Dragisic

Pediatric Cardiology Kansas City, MO Medical Doctor

NPI 1053739888 CMS profile 8376973

2401 Gillham Rd, Kansas City, MO 64108

Open in the dashboard

General payments

$27,914

86 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nikola Dragisic of Kansas City, MO is reported in the CMS Open Payments database as having received $27,914 across 86 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Pediatric Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $822 22
2024 General $2,150 29
2023 General $447 8
2022 General $726 14
2021 General $5,132 10
2020 General $18,636 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nikola Dragisic
  • Pediatric Cardiology median
  • Middle half of Pediatric Cardiology
  • National median

In program year 2025, general payments to Nikola Dragisic were reported at $822. Among 1,168 Pediatric Cardiology profiles paid that year, the median was $146 and the middle half received between $47 and $670.

Show as a table
Year Nikola Dragisic Pediatric Cardiology median Middle half National median
2019 $0 $124 $35–$516 $163
2020 $18,636 $70 $23–$326 $114
2021 $5,132 $112 $27–$445 $132
2022 $726 $129 $36–$680 $149
2023 $447 $149 $38–$826 $160
2024 $2,150 $131 $37–$652 $164
2025 $822 $146 $47–$670 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Abbott Laboratories $14,255 23 payments
  2. Boston Scientific Corporation $10,802 15 payments
  3. Medtronic, Inc. $1,491 10 payments
  4. Biosense Webster, Inc. $1,365 38 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Grant $23,636 4 payments
  2. Food and Beverage $2,979 76 payments
  3. Travel and Lodging $1,298 6 payments
Products named General payments · program years 2020–2025
  1. GENERAL - BRADY $5,000 1 payment
  2. EMBLEM S ICD ELECTRODE DELIVERY SYSTEM $5,000 1 payment
  3. EVERA MRI XT DR SURESCAN $1,474 9 payments
  4. Carto 3 $1,096 33 payments
  5. ACCOLADE SR $261 4 payments
  6. LUX-Dx Insertable Cardiac Monitor $228 5 payments
  7. QDOT MICRO $216 3 payments
  8. ENSITE PRECISION Electrophysiology $199 4 payments
  9. ENSITE PRECISION Structural Heart $174 5 payments
  10. EnSite Precision Cardiac Mapping System $121 8 payments
  11. Other $235 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

86 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Cardiology in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record